Biblio
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. Haematologica. 2024.
Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma. Hum Vaccin Immunother. 2024;20(1):2309701.
. Pembrolizumab in relapsed or refractory Richter syndrome. Br J Haematol. 2020.